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ABSTRACT
Binding MOAD (Mother of All Databases) is a
database of 9836 protein–ligand crystal structures.
All biologically relevant ligands are annotated,
and experimental binding-affinity data is reported
when available. Binding MOAD has almost doubled
in size since it was originally introduced in 2004,
demonstrating steady growth with each annual
update. Several technologies, such as natural
language processing, help drive this constant
expansion. Along with increasing data, Binding
MOAD has improved usability. The website now
showcases a faster, more featured viewer to
examine the protein–ligand structures. Ligands
have additional chemical data, allowing for chemin-
formatics mining. Lastly, logins are no longer
necessary, and Binding MOAD is freely available to
all at http://www.BindingMOAD.org.
INTRODUCTION
The ﬁeld of structure-based drug design relies on
high-quality databases of protein–ligand structures to
develop the best computational tools. There are several
available, including but not limited to Binding MOAD
(1), PDBbind (2), LPDB (3), Relibase (4), BindingDB
(5), PDBLig (6), MSDsite (7), eF-Site (8), PDB-Ligand
(9), SuperLigands (10), PLD (11), HET-PDB (12), sc-PDB
(13), PDBsite (14), Ligand Depot (15), AﬃnDB (16) and
KiBank (17). Each database has a unique focus and
incorporates diﬀerent data content, chemical structures,
and/or analysis tools.
Our development of Binding MOAD focuses on
providing the largest collection of high-quality, protein–
ligand complexes. Each structure is hand curated by
reading the crystallography paper which presents the
structure in the literature; this is used to validate ligands
and acquire binding aﬃnities. Binding MOAD contains
all appropriate protein–ligand complexes: protein–ligand,
protein-cofactor and protein–ligand-cofactor. It also
presents complexes even when no binding data is
currently available. This makes it the largest database of
its type. Here, we discuss the latest update to the Binding
MOAD database, outlining improved access, the
addition of new data and the incorporation of new tools.
BINDING MOAD COMPOSITION
Binding MOAD is constructed with a top-down
approach, starting with all entries in the PDB (18) and
eliminating structures which are inappropriate. This is
more eﬃcient than a ground-up approach of reading the
literature as a whole to identify appropriate complexes.
Each entry in Binding MOAD must have resolution better
than 2.5A ˚ , and each entry must contain a valid ligand.
Valid ligands are biologically relevant small molecules
and can include agonists, antagonists, cofactors, inhibi-
tors, allosteric regulators, enzymatic products, etc.
Covalently attached molecules (covalent inhibitors or
posttranslational modiﬁcations to the protein) are not
considered valid ligands. The focus is proteins binding
small molecules, so peptides larger than 10 amino
acids and chains of greater than four nucleic acids are
not considered valid ligands. Many small molecules
present in a crystal structure are not considered
biologically relevant because they are part of the crystal-
lization matrix and an artifact of the protein in an
artiﬁcial condensed phase. Such molecules include
solvents, buﬀers, detergents and salts, but care must be
taken because some small molecules are valid ligands
in some structures but additives in others. Examples of
such are sugars, membrane components, small organic
molecules (e.g. toluene) and metabolites (e.g. citrate).
Figures 1 and 2 illustrate the wide distribution of
data available in Binding MOAD, in terms of binding
aﬃnity and size, respectively.
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of 90% sequence identity. By choosing one representative
of each family (the ligand with the best aﬃnity), we can
create a non-redundant set which removes any skew
resulting from proteins that are heavily represented in the
PDB (18). Protein families are also grouped by function
using Enzyme Classiﬁcation numbers and our own
non-enzymatic classiﬁcations. At the bottom of the data
page for each complex in Binding MOAD, the entire
protein family is reported and a link is provided to view
all the data for that functional class (Figure 3). This
allows a user to start at a particular complex important
to his/her research, and from there, jump to other
related structures.
GROWTH
Since its introduction in 2004, Binding MOAD has
regularly expanded its collection with new data.
Originally it contained 5331 protein–ligand complexes,
and it has increased by almost 1500 each year, growing to
6638 in 2005, 8250 in 2006 and 9836 with the latest update.
This steady growth mirrors the growth of the PDB; each
year’s update has consistently shown that one-fourth of
the PDB structures meet our criteria for inclusion in
Binding MOAD. Of the 9836 entries in the current
version, 2950 (30%) have binding data curated from
literature. It contains 3153 protein families and 5074
unique ligands.
As noted earlier, each crystallography paper is read to
classify the ligands and extract aﬃnity data for the ligand.
Thus, adding new data to Binding MOAD involves
reading a tremendous number of journal articles for
manual annotation. After reading 10000 papers, we
have turned to automated methods to facilitate the
process! A workﬂow tool, Binding Unstructured Data
Analysis (BUDA), has been developed employing natural
language processing (NLP) to evaluate and organize the
papers for each update cycle. It identiﬁes key sentences
and phrases in papers and uses a weighted-scoring
algorithm to rank the likelihood that the key sentences
and phrases contain binding data. The NLP portion
of BUDA is built upon the General Architecture for
Text Engineering (GATE) framework (gate.ac.uk). The
workﬂow portion of BUDA is used by the curators to
organize the data for the annotation process. From the
workﬂow interface, the curators can sort the articles by
their weighted scores, review texts with highlights noting
key phrases or sentences, and update the data into Binding
MOAD. One of the key features is the ability to score a
paper as lacking aﬃnity data; it is a signiﬁcant time-saving
measure, rather than reading the paper in vain. While
NLP can be used to speed up and guide the literature step,
we unfortunately cannot use NLP to automatically extract
the desired information. Many papers give aﬃnity
information for related systems when such information
is unavailable for the exact complex in the crystal structure
(e.g. aﬃnities for wild-type protein are reported but the
structures are all mutants or only the range of aﬃnities is
given for an entire inhibitor class). The data in Binding
MOAD is for precisely the protein–ligand pair in the
crystal structure, so data must be speciﬁc for that ligand
bound to that exact protein. This evaluation must be made
by hand.
AVAILABILITY
We have recently removed the need for users to login,
and data is now freely accessible to all private com-
panies, non-proﬁts and foreign institutions. A comma-
separated values (CSV) ﬁle is available to obtain the
binding data and ligand information, organized by
protein class and family. The CSV format was chosen
for wide portability. Structures are also available as
biounit ﬁles.
PLATFORM
Binding MOAD is built on proven technologies. The
database is based on the Java 2 Platform, Enterprise
Edition (J2EE), using an open-source JBoss Application
Server, Enterprise JavaBeans (EJB) and a MySQL
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Figure 1. Distribution of binding aﬃnities in Binding MOAD. Data is
labeled as Kd (blue), IC50 (yellow) and Ki (red). For this ﬁgure, binding
aﬃnities were simply converted to free energies by RT  ln(aﬃnity).
While this conversion not strictly appropriate for Ki or IC50, it provides
a comparison for the reader.
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Figure 2. Distribution of the sizes of 5074 unique ligands in Binding
MOAD. The largest ligands are peptides, short oligonucleotides and
complex sugars.
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compliant, easy-to-use website that uniﬁes the presenta-
tion of structural, chemical and binding data in one
simple format. In particular, the structure of the
database allows us to expand the features and add new
data easily.
RECENT IMPROVEMENTS
A screenshot of the modiﬁed layout for a data page
in Binding MOAD is shown in Figure 3. New data has
been incorporated about the valid ligands in each
structure, including interactive 2D pictures, chemical
formulae and the corresponding SMILES strings. As
before, all ligands are noted as valid or invalid. When a
hetgroup is considered part of the protein (glycosylation,
catalytic metal, HEME group, etc.), it is not listed on the
data page.
The greatest improvement comes as a new tool for
viewing the complex in 3D. The GoCavViewer has been
replaced by the EolasViewer; screenshot of the viewer is
shown in Figure 4. As before, the viewer is capable of
displaying the ligand pocket using both ball-stick and
surface representations; the surfaces come from our
code GoCAV which was speciﬁcally developed for
Binding MOAD (19). However, EolasViewer incorporates
signiﬁcant improvements in the areas of performance,
visual quality and back-end ﬂexibility for future applica-
tion development eﬀorts.
The new viewer is built using the Eolus platform
from Metamatics. Like its predecessor, the Eolus-based
viewer is built using a Java framework, and the Binding
MOAD website deploys it as a WebStart application.
Eolus uses Jogl (Java Bindings for OpenGL) to fully
utilize the 3D acceleration features available in nearly all
modern computers. These two technologies, Java
WebStart and OpenGL, provide nearly hands-free deploy-
ment of the software, together with state-of-the-art
performance and visual quality. It takes advantage of
rendering algorithms and OpenGL Shader Language
Figure 3. Screenshot of the data page for 3ERK, showing the additional ligand data and the connectivity to proteins with similar structure
and function.
D676 Nucleic Acids Research, 2008, Vol. 36, DatabaseissueFigure 4. EolasViewer for 3ERK. The SB4 ligand is shown in ball in stick inside the pocket. The surfaces shown are the ligand surface in blue, the
binding site in red and the solvent-exposed regions of the binding site are in green. (Top) The protein backbone is shown as a gray ribbon, and in the
close-up (Bottom), the backbone is colored by B-factors.
Nucleic Acids Research, 2008,Vol. 36,Database issue D677(GLSL) to provide enhanced representation styles.
The surface representation has been expanded to a fully
transparent polygon surface. The proteins are rendered
as ribbons by default, and the entire protein can now
be rendered either as ribbon or ball-stick (the
GoCavViewer was limited to displaying only residues
that comprised the binding site). Finally, Eolus is a
platform for structural biology, being developed in
conjunction with this and other tools.
FUTURE DIRECTIONS
The data is currently organized with respect to protein
structure and function, but we will expand the organiza-
tion of the ligands by their chemical nature. At this
time, ligands are annotated by their 3-letter HET codes,
but full names will soon be added. A single-click search
links all structures that contain the same molecule,
but that is the extent of cross-linking by ligand data.
We are adding similarity-based searches for the ligands.
This eﬀort will incorporate the new remediated ligand
data released by the PDB consortium, and we look to
cross-link our information with other major databases
that focus on proteins and ligands. Furthermore, we look
to use our text-mining tools to extend our search for
aﬃnity data beyond the crystallography literature. Lastly,
Binding MOAD adds data once a year, but we look to
make this a semi-annual event, given the success with
NLP. Such NLP-based, text-mining approaches can be
readily applied to other bioinformatic projects. This
technology can be used to extract a wide variety of
data—not just binding information—from the huge body
of literature available today.
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